NASDAQ 100 % ()
FTSE 100 % ()
BTC/USD % ()
EUR/USD % ()
GBP/USD % ()
GOLD % ()


Danaher Corporation New York Stock Exchange
Open: $237.56 High: $239.45 Low: $232.71 Close: $238.004
Range: 2021-01-21 - 2021-01-22
Volume: 4,379,581
Market: Closed
Powered by Finage Stock APIDelayed data
Danaher Corporation 2200 Pennsylvania Avenue, NW Washington DC, 20037-1701
Danaher Corp designs, manufactures and markets professional, medical, industrial and commercial products and services. It markets its products under the brand of Beckman Coulter, Aperio, Dexis, Chemtreat and others.
  • CEO: Thomas P. Joyce
  • Employees: 67,000
  • Sector: Healthcare
  • Industry: Medical Diagnostics & Research
DHR News
Latest news about the DHR
  • Honeywell (HON) Unveils Latest Version of CPCMS for Aircraft

    Honeywell's (HON) latest version of the Cabin Pressure Control and Monitoring System facilitates in monitoring and controlling the air pressure inside the aircraft.

    View More →
  • General Electric (GE) to Offer HA Gas Turbines in South Korea

    General Electric (GE) receives an order from Tongyeong Eco Power to supply more than 1 gigawatt of power generation equipment at the Tongyeong combined cycle power plant in South Korea.

    View More →
  • Cepheid Receives Health Canada License for SARS-CoV-2, Flu A, Flu B and RSV Combination Test

    Challenged by Similar Clinical Presentations, Accurate Detection & Differentiation of all 4 Viruses is Critical for Clinicians This Flu SeasonSUNNYVALE, Calif., Jan.

    View More →
  • A Look Into Danaher's Debt

    Over the past three months, shares of Danaher (NYSE:DHR) rose by 7.53%. Before having a look at the importance of debt, let us look at how much debt Danaher has.Danaher's Debt Based on Danaher's financial statement as of October 22, 2020, long-term debt is at $21.81 billion and current debt is at $19.70 million, amounting to $21.83 billion in total debt. Adjusted for $5.69 billion in cash-equivalents, the company's net debt is at $16.14 billion.Let's define some of the terms we used in the paragraph above. Current debt is the portion of a company's debt which is due within 1 year, while long-term debt is the portion due in more than 1 year. Cash equivalents include cash and any liquid securities with maturity periods of 90 days or less. Total debt equals current debt plus long-term debt minus cash equivalents.Shareholders look at the debt-ratio to understand how much financial leverage a company has. Danaher has $72.89 billion in total assets, therefore making the debt-ratio 0.3. As a rule of thumb, a debt-ratio more than one indicates that a considerable portion of debt is funded by assets. A higher debt-ratio can also imply that the company might be putting itself at risk for default, if interest rates were to increase. However, debt-ratios vary widely across different industries. A debt ratio of 35% might be higher for one industry and average for another.Why Debt Is Important Besides equity, debt is an important factor in the capital structure of a company, and contributes to its growth. Due to its lower financing cost compared to equity, it becomes an attractive option for executives trying to raise capital.Interest-payment obligations can impact the cash-flow of the company. Equity owners can keep excess profit, generated from the debt capital, when companies use the debt capital for its business operations.Looking for stocks with low debt-to-equity ratios? Check out Benzinga Pro, a market research platform which provides investors with near-instantaneous access to dozens of stock metrics - including debt-to-equity ratio. Click here to learn more. See more from Benzinga * Click here for options trades from Benzinga * 10 Health Care Stocks Showing Unusual Options Activity In Today's Session(C) 2021 Benzinga does not provide investment advice. All rights reserved.

    View More →
  • Danaher CEO To Comment On Financial Performance

    Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment today on the Company's fourth quarter 2020 performance in a presentation at the J.P. Morgan Healthcare Conference at 10:50 a.m. ET.

    View More →
  • 7 Top Corporate Behemoths With Immense Upside Left in 2021

    We have narrowed down our search to seven corporate behemoths that have strong growth potential in 2021. These are: TSLA, SQ, NVDA, FB, AVGO, DHR and QCOM.

    View More →
  • Danaher Could Trade Higher

    Danaher Corp. is a science and technology innovator and will be wrapping up the JP Morgan health care conference on Wednesday, hopefully with an update on their vaccine progress. Let's check out the charts.

    View More →
  • Apple Stock, Chipotle Headline 5 Top Stocks Flashing Buy Signals

    Five top stocks flashing buy signals include Apple, Chinese internet giant Tencent and fast-casual Mexican chain Chipotle Mexican Grill.

    View More →
  • Dow Jones Turns Lower On Sen. Manchin Comment While Nasdaq Leads, Hits New High

    The Dow Jones Industrial Average traded slightly lower in today's stock market after the major indexes all hit fresh record highs the day prior.

    View More →
  • Why Danaher (DHR) is Poised to Beat Earnings Estimates Again

    Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

    View More →
  • Danaher To Present At J.P. Morgan Healthcare Conference

    Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021 at 10:50 a.m. ET. The audio will be simultaneously webcast on and the presentation will be archived on

    View More →
  • Danaher Schedules Fourth Quarter 2020 Earnings Conference Call

    Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2020 on Thursday, January 28, 2021 beginning at 8:00 a.m. ET and lasting approximately 1 hour.

    View More →
  • IBD 50 Stocks To Watch: This Stock Is Nearing A New Cup-Base Buy Point

    Among top growth stocks to watch is Danaher, as the IBD 50 Stocks To Watch pick approaches a new buy point.

    View More →
  • Griffon (GFF) Divests System Engineering Group Business

    Griffon's (GFF) sale of the System Engineering Group business unit will enable it to better focus on and efficiently direct resources to its core defense electronics and systems product lines.

    View More →
  • 15 Largest Medical Device Companies in the World

    In this article, we are going to list the 15 largest medical device companies in the world. Click to skip ahead and jump to the 5 largest medical device companies in the world. What are the largest medical device companies in 2021? The sudden emergence of serious infections such as the novel coronavirus is expected to drive […]

    View More →
  • Honeywell (HON) Displays Bright Prospects, Risks Persist

    Honeywell (HON) is poised to gain from strength in its defense and space businesses and acquired assets. High debt profile remains a concern.

    View More →
  • The Zacks Analyst Blog Highlights: BABA, DHR, UPS, AXP and MAR

    The Zacks Analyst Blog Highlights: BABA, DHR, UPS, AXP and MAR

    View More →
  • Top Research Reports for Alibaba, Danaher & United Parcel Service

    Top Research Reports for Alibaba, Danaher & United Parcel Service

    View More →
  • Danaher Corporation's (NYSE:DHR) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

    Danaher's (NYSE:DHR) stock up by 5.6% over the past three months. As most would know, long-term fundamentals have a...

    View More →
  • GE's Curious Case of a $47 Million CEO Bonus

    (Bloomberg Opinion) -- I have questions about Larry Culp’s $47 million payday at General Electric Co. GE last week hit the share performance threshold that triggers the first tier of a one-time equity grant for Culp that could ultimately amount to as much as $230 million, according to a Bloomberg News analysis. The bonus was originally set up when Culp was named chief executive officer in 2018. It was meant to reward the former Danaher Corp. CEO for taking on the stewardship of a company whose best days looked to be behind it and to incentivize him to follow through on a turnaround job that at times has seemed impossible. One of those times was earlier this year, when the pandemic engulfed the crown jewel aviation unit that had been the company’s salvation through years of woes in the gas turbine and insurance businesses. With this unprecedented and unpredictable event upending the first tangible signs of stabilization at GE, it felt fair to give Culp some more time to steer the company into a better direction. So in August, the company rejiggered the terms of the pay package.GE’s board extended Culp’s contract through at least 2024 with an option for a one-year extension, giving him a few extra years for his turnaround efforts to yield results; fine. But it made the curious decision to also lower the stock performance thresholds. The trigger for the lowest tier of Culp’s pay package dropped to about $10 from nearly $19. As long as Culp could keep GE’s stock price in the $10 range for a month, he would lock in a payout of at least $47 million. In August, GE’s stock price was hovering around $6, so getting to $10 required a significant rally. But as I wrote at the time, considering Culp had five years to hit that target and the stock traded higher than that when he took over, it hardly felt aspirational enough to warrant a $47 million payday. It turns out Culp only needed four months, not five years, to hit the target after a furious fourth-quarter rally on vaccine optimism and an improving outlook for free cash flow. GE’s August decision to lower the bar for Culp felt like an admission that the company’s long-term prospects had dulled because of its near-term challenges. That's why it was so surprising when just one month later Culp told a Morgan Stanley conference that GE would generate positive free cash flow in the second half of 2020 — a prediction the CEO had been hesitant to make on the company’s earnings call in July despite repeated questions from analysts on this front. It was even more surprising when GE said in October that it had managed to generate positive free cash flow in the third quarter, compared with the average analyst expectation that it would burn through nearly $1 billion. The company has forecast “at least” $2.5 billion in cash flow for the fourth quarter and a positive number in 2021. Why again did Culp need a lower bar? After bouncing around the $6 to $7 range for several months, GE’s rally took off in late September. With a week and a half left in 2020, GE shares are down only about 5% in a year that’s brought incredible disruption not just to the company but the world. It’s a serious feat, and there's no denying that Culp’s progress has been impressive. Through a combination of asset sales, cost cuts and internal overhauls, GE is a healthier and more transparent company than it was when he started. But while many (including me) have had their doubts at times, Culp has always been one of GE’s most prominent believers. It’s curious that this optimism didn’t extend into negotiations around his pay package. To get the full $230 million, Culp has to push GE’s stock price to around $17, down from an initial goal of about $31. Again, this is a significant jump — but he’s still got until 2025, and if the recent trajectory of the company’s cash flow reboot is anything to go by, that feels doable. Meanwhile, back in the present, the company has eliminated 13,000 jobs in its aviation unit to adjust for the drop in demand amid the pandemic, and division chief John Slattery warned last month that more cuts are coming. Culp has indicated the bulk of these job reductions will be permanent, leading to a leaner and more profitable aviation division once travel recovers but an uncertain future for many former employees. Certainly less certain than Culp’s own future. This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Brooke Sutherland is a Bloomberg Opinion columnist covering deals and industrial companies. She previously wrote an M&A column for Bloomberg News.For more articles like this, please visit us at now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

    View More →